Integrated metabolomics analysis identifies distinct amino acid signatures in chronic hepatitis B patients with metabolic dysfunction-associated steatotic liver disease

BackgroundChronic hepatitis B (CHB) and metabolic dysfunction-associated steatotic liver disease (MASLD) frequently coexist and synergistically accelerate progression to end-stage liver disease. However, the metabolic differences distinguishing CHB alone from CHB with MASLD remain poorly defined.Met...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yanping Lan, Zitao Zhou, Qunfang Huang, Xin Yang, Xinrong Lu, Renquan Jiang, Yujue He, Xinyao Yang, Detai Ye, Zixin Chen, Can Liu, Qishui Ou, Zhen Xun
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-04-01
Colecção:	Frontiers in Cellular and Infection Microbiology
Assuntos:	amino acid biomarker chronic hepatitis B MASLD metabolomics
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fcimb.2026.1783221/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!